Does Michael Burry Know Something Wall Street Doesn't? The Investor of "The Big Short" Fame Just Made a Striking Move.

Michael Burry's Scion Asset Management significantly shifted its portfolio in Q2, making UnitedHealth Group (UNH) its largest position through the acquisition of 20,000 shares and call options on 350,000 more, abandoning prior bearish tech bets. This contrarian move targets the struggling healthcare giant, which has seen its stock fall 50%, missed Q2 earnings, and faces a DOJ probe and rising costs. Burry's bet suggests a conviction in UNH's long-term value, given its market leadership, efforts to mitigate headwinds, and its current valuation near a decade low, signaling a potential recovery play for the leading U.S. health insurer.

Analysis

Scion Asset Management, led by contrarian investor Michael Burry, executed a significant portfolio shift in the second quarter, establishing UnitedHealth Group (UNH) as its largest position. This bullish stance was built through the acquisition of 20,000 shares and, more notably, call options on 350,000 shares, with the options position alone constituting an 18% portfolio weight. This move is particularly striking given UNH's recent performance, including a stock price decline of nearly 50% over the past year, a Q2 adjusted EPS miss ($4.08 reported vs. $4.48 estimated), and persistent headwinds from a Department of Justice probe and rising medical costs. The investment thesis appears to be a classic value and recovery play, predicated on UNH's durable market leadership as the largest U.S. health insurer and its current valuation near a decade-low at 13x trailing-12-month earnings. Management has outlined a clear strategy to address current challenges by exiting unprofitable plans, raising premiums, and leveraging AI to potentially cut $1 billion in costs for its Optum unit next year. Burry's pivot, which included closing out previous bearish bets on technology stocks like Nvidia and Alibaba, signals a conviction that UNH's issues are temporary and that its proactive measures will drive a return to earnings growth in the coming year, making the current depressed price an opportunity.

Key Decisions for Investors

• Investors with a long-term horizon and higher risk tolerance could consider the nearly 50% stock decline and decade-low valuation as a strategic entry point, aligning with the contrarian view that current headwinds are priced in.
• It is critical to monitor UNH's ability to manage rising medical costs and the progression of the Department of Justice probe, as these are the primary risks that could undermine the recovery thesis.
• The significant use of call options in this strategy suggests that sophisticated investors might explore options to gain leveraged exposure to a potential rebound, while acknowledging the inherent risks of time decay and volatility.
• Investors should evaluate UNH's specific cost-cutting measures, such as the projected $1 billion in AI-driven savings, against those of its peers to determine if it can regain a competitive advantage in an industry facing universal cost pressures.